Form 13G Voyager Therapeutics For: 18 February
#Form 13G #Voyager Therapeutics #U.S. SEC #beneficial ownership #passive investor #February 18 2024
📌 Key Takeaways
- Form 13G filing concerning Voyager Therapeutics
- Filed with U.S. SEC on 18 February 2024
- Documents beneficial ownership and passive investor status
- Serves compliance with SEC disclosure requirements
📖 Full Retelling
On 18 February 2024, a Form 13G filing related to Voyager Therapeutics was submitted to the U.S. Securities and Exchange Commission. The document, which is required by SEC rules, details beneficial ownership stakes in the company and identifies the filer as a passive investor. The filing is part of the company’s ongoing compliance with securities disclosure regulations.
🏷️ Themes
SEC filings, Investment disclosure, Passive investing, Corporate governance
Entity Intersection Graph
No entity connections available yet for this article.